Eli Lilly and Company News - June 26, 2026
🟢 LLY extends move to 6.3% up
LLY is trading at $1199.00, up 6.3% versus the comparison close of $1127.69 during regular trading. This is a price-movement alert; no separate...
🟢 LLY up 4.1% today as Eli Lilly's Jaypirca receives positive EU recommendation for CLL
Eli Lilly (LLY) is trading 4.1% up at $1,173.96 today, following a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products...
Eli Lilly offers Zepbound for $50, targeting 20 million Medicare patients
Eli Lilly and Company will launch its Medicare GLP-1 Bridge program on July 1, 2026. Eligible Medicare Part D patients will pay $50 per month for Zepbound...